Hereditary cardiology testing Hero
shape-element-one
shape-element-two
Cardiology

Hereditary Cardiology Testing

Flexible options to identify patients and families at risk for inherited cardiovascular conditions.

Why Ambry

More than 1 in 60 people have an inherited cardiovascular condition, such as cardiomyopathies, arrhythmias, thoracic aortic aneurysms and dissections, and familial hypercholesterolemia. Ambry’s approach combines a flexible, clinically driven test menu with a rigorous evidence base to help you identify those at risk and determine life-saving treatment and management decisions with your cardiology patients.

We strive to offer results that minimize ambiguity and uncertainty—standing behind our work with service and support, to ensure that the testing you choose yields clear, actionable insights to guide complex decisions in patient care.

MOST FREQUENTLY ORDERED

Highlighted Cardiology Tests

Highlighted Tests
FHNext®
4 Genes
Targeted panel for patients with familial hypercholesterolemia, one of the most common genetic conditions
Highlighted Tests
HCMNext®
30 Genes
Multi-gene panel that can be ordered individually or on a reflex basis for patients with hypertrophic cardiomyopathy (HCM)
Highlighted Tests
LongQTNext™
17 Genes
Targeted panel for patients with long QT syndrome (LQTS)
Highlighted Tests
RhythmNext™
42 Genes
Multi-gene panels for patients with long QT syndrome (LQTS)
Highlighted Tests
TAADNext®
35 Genes
Next generation sequencing (NGS) panel that analyzes 35 genes associated with thoracic aortic aneurysms and dissections (TAAD), Marfan syndrome, or related disorders

Additional Testing Areas

solutions-testing-menu-oncology-02b 1
Oncology
solutions-testing-menu-neurology-02b-1[1]
Neurology
solutions-testing-menu-exome-general-genetics-03a-1[1]
Exome (Rare Disease) + General Genetics